4 RESULTS
COMMENT So far, the data are very preliminary. Some responders/survivors are cognitively impaired. There are subjects who appear to be amyloid-positive or tau-positive, but it is not clear what the overlap is between them. The number of tau and amyloid scans done ...
COMMENT It is a curious fact that most radiologists, and even most neurologists, when presented with an MRI scan of a patient suspected to have a neurodegenerative disease, rarely pay much attention to the morphology of the brain, other than to comment on ...
COMMENT If the results from the bapineuzumab study are taken in the context of Lilly’s prespecified analysis of pooled data from the EXPEDITION and EXPEDITION2 solanezumab trials, subdivided into those with mild versus moderate impairment, it would suggest that ...
COMMENT The article by Boustani et al., appearing in the May issue of the Journal of General Internal Medicine, describes a randomized clinical trial to test the effectiveness of a Clinical Decision Support System (CDSS), which was employed to: 1) alert ...
